← Back to Search

Behavioural Intervention

IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) for Heart Disease

N/A
Waitlist Available
Led By Mansha Mirza, PhD, OTR/L
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This trial tests IPROACTIF, a program where occupational therapists help older adults and people with chronic diseases stay healthy. The program includes check-ups and sessions to manage health, stay active, and improve thinking skills. It aims to see if participants perform better in daily activities and overall health compared to usual care.

Eligible Conditions
  • Heart Disease
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Executive functioning using the Dimensional Change Card Sort Test
Executive functioning using the Executive Function Performance Test
Performance of daily living tasks using the Performance Assessment of Self-care Skills
+3 more
Secondary study objectives
Health related quality of life using the PROMIS Global Health Measure (physical and mental subscales)
Participation in life activities and roles using the Late Life Functioning and Disability Index
Physical activity level
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual careExperimental Treatment1 Intervention
Participants in the control group will receive usual services which might include primary care and prescription medications for chronic disease management.
Group II: IPROACTIFExperimental Treatment1 Intervention
10 weekly sessions. First two sessions focus on comprehensive assessment of physical and executive functioning, assessment of home safety and accessibility, assessment of ADL/IADL competence and performance in context; information in these areas is used by the interventionist to collaboratively identify three patient-centered goals. Goal planning is followed by 10 treatment sessions. Treatment sessions focus on chronic disease education, problem solving issues related to disease management by modifying daily routines, recommendations for embedding physical activity in everyday tasks, and environmental modifications or activity adaptations to increase ADL/IADL independence.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
632 Previous Clinical Trials
1,567,670 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,958 Total Patients Enrolled
Mansha Mirza, PhD, OTR/LPrincipal InvestigatorUniversity of Illinois at Chicago
~11 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top